n.a. (TKMR)

4.02
0.08 1.95
NASDAQ
Prev Close 4.10
Open 4.22
Day Low/High 3.98 / 4.33
52 Wk Low/High 4.01 / 26.73
Volume 346.21K
Exchange NASDAQ
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Tekmira Pharmaceuticals (TKMR) Shares Cross Below Book Value

Tekmira Pharmaceuticals (TKMR) Shares Cross Below Book Value

In trading on Tuesday, shares of Tekmira Pharmaceuticals Corp crossed below their last reported book value — defined as common shareholder equity per share — of $10.97, changing hands as low as $10.77 per share. Tekmira Pharmaceuticals Corp shares are currently trading off about 1.6% on the day.

Tekmira Pharmaceuticals Enters Oversold Territory (TKMR)

Tekmira Pharmaceuticals Enters Oversold Territory (TKMR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Tekmira Pharmaceuticals (TKMR) Weak On High Volume

Tekmira Pharmaceuticals (TKMR) Weak On High Volume

Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a weak on high relative volume candidate

Tekmira Pharmaceuticals (TKMR): Today's Weak On High Volume Stock

Tekmira Pharmaceuticals (TKMR): Today's Weak On High Volume Stock

Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a weak on high relative volume candidate

'Mad Money' Lightning Round: Buy, Buy, Buy Yahoo!, Not Alibaba

'Mad Money' Lightning Round: Buy, Buy, Buy Yahoo!, Not Alibaba

Cramer is taking a pass on Petrobras and is still on the fence about Gogo.

Jim Cramer's 'Mad Money' Recap: 'Hit and Run' Investors Are the Worst

Jim Cramer's 'Mad Money' Recap: 'Hit and Run' Investors Are the Worst

Don't buy into the panic, only buy stocks you understand and are willing to hold onto for the long term, Cramer says.

Tekmira Pharmaceuticals Becomes Oversold (TKMR)

Tekmira Pharmaceuticals Becomes Oversold (TKMR)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Tekmira Provides Corporate Update And Announces First Quarter 2015 Results

Tekmira Provides Corporate Update And Announces First Quarter 2015 Results

Conference Call at 4:30 pm Eastern Time Today

June 12th Options Now Available For Tekmira Pharmaceuticals (TKMR)

June 12th Options Now Available For Tekmira Pharmaceuticals (TKMR)

Investors in Tekmira Pharmaceuticals Corp saw new options begin trading today, for the June 12th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TKMR options chain for the new June 12th contracts and identified one put and one call contract of particular interest.

Tekmira Pharmaceuticals (TKMR) Weak On High Volume

Tekmira Pharmaceuticals (TKMR) Weak On High Volume

Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a weak on high relative volume candidate

Interesting TKMR Put Options For June 5th

Interesting TKMR Put Options For June 5th

Investors in Tekmira Pharmaceuticals Corp saw new options begin trading today, for the June 5th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TKMR options chain for the new June 5th contracts and identified the following put contract of particular interest.

Tekmira And Collaborators Publish Positive Preclinical Ebola Survival Data In Nature Journal

Tekmira And Collaborators Publish Positive Preclinical Ebola Survival Data In Nature Journal

Findings Validate Adaptability of siRNA-LNP to Rapidly Target Emerging Viral Strains

FDA Modifies Partial Clinical Hold On Tekmira's TKM-Ebola IND To Allow Multiple Dosing Of Healthy Volunteers

FDA Modifies Partial Clinical Hold On Tekmira's TKM-Ebola IND To Allow Multiple Dosing Of Healthy Volunteers

Multiple Dosing Cohort of the Phase I Clinical Study of TKM-Ebola Expected to be Initiated in Q2

Tekmira Presents Preclinical Results Demonstrating Super-Additive Effects On Plasma Triglyceride Lowering By Silencing Of ApoC3 And ANGPTL3 Genes

Tekmira Presents Preclinical Results Demonstrating Super-Additive Effects On Plasma Triglyceride Lowering By Silencing Of ApoC3 And ANGPTL3 Genes

Results of TKM-HTG for the Treatment of Hypertriglyceridemia Presented at Keystone Symposia Conference

Tekmira Pharmaceuticals (TKMR) Highlighted As Today's Perilous Reversal Stock

Tekmira Pharmaceuticals (TKMR) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a "perilous reversal" (up big yesterday but down big today) candidate

Tekmira Provides Corporate Update And Announces Year-End 2014 Results

Tekmira Provides Corporate Update And Announces Year-End 2014 Results

Conference Call at 4:30 pm Eastern Time Today

TKM-Ebola-Guinea Enters Phase II Clinical Study In Sierra Leone

TKM-Ebola-Guinea Enters Phase II Clinical Study In Sierra Leone

Patient Recruitment Initiated